Vicious rivals are making peace in the tech world. IBM and Apple have been working together to manufacture iPad and iPhone apps for IBM customers, including Citigroup and Sprint. It's an example of a business strategy known as 'coopetition,' defined as 'collaboration between business competitors, in the hope of mutually beneficial results.' Apple wants to make inroads into the corporate market for PCs, and IBM wants to use Macs and iPads, fitted with IBM software for use by IBM corporate clients. A big selling point to corporations is that it's much easier to manage and integrate Macs than PCs in a corporate environment. With love in the air in Silicon Valley, we decided to check TheStreet Quant Ratings for stocks in the IT consulting sub-sector, which would be good investments. Number 3 is CGI Group. With an 'A' rating, the company's strengths can be seen in its attractive valuation levels and increase in net income. 2nd is, Amdocs Limited. This rating is an 'A+.' Amdocs thrives in its solid stock price performance and revenue growth. Number 1 is Accenture. This too has an 'A+' rating. The company flourishes in its revenue growth and solid stock price performance. TheStreet Ratings are algorithmic stock picks based on 32 major data points. S&P 500 stocks rated 'buy' yielded a 16-and-a-half-percent return in 2014, beating the S&P 500 Total Return Index by more than 300 basis points. For the full reports on these stocks, you can check out TheStreet.com/QuantRatings.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.